GeneDx Holdings Corp. (WGSWW)

Market Cap	3.91B
Revenue (ttm)	402.19M
Net Income (ttm)	2.08M
Shares Out	28.90M
EPS (ttm)	0.07
PE Ratio	1,878.59
Forward PE	370.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,400
Open	0.0321
Previous Close	0.0377
Day's Range	0.0320 - 0.0377
52-Week Range	0.0300 - 0.3410
Beta	2.05
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 17, 2026

About WGSWW

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2017
• Employees: 1,000
• Stock Exchange: NASDAQ
• Ticker Symbol: WGSWW
• Website: https://www.genedx.com